P43. Therapy-related leukemia after lung cancer therapy

Abstract

Background Therapy-related leukemia defined by the World health Organization 2008 classification scheme of hematolymphoid tumors including therapy-related acute myeloid neoplasms (t-AML), myelodysplastic syndrome (t-MDS). They occur as late complication of cytotoxic chemotherapy, radiation therapy and molecular target agents therapy against primary neoplasms. Recently, for lung cancer chemotherapy, new anti-cancer agent and molecular target agents are increased and more intensification chemotherapy performed. We report that we reviewed t-AML cases who survived from lung cancer and suffered t-AML.